search
Back to results

Effectiveness of Psychological Interventions in Haemophilia (PSY_HaEMOPEQ)

Primary Purpose

Haemophilia

Status
Completed
Phase
Not Applicable
Locations
Portugal
Study Type
Interventional
Intervention
Hypnosis
Cognitive-Behavioral Therapy
Sponsored by
University of Minho
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Haemophilia focused on measuring Haemophilia, RCT, Pain, Hemarthrosis, Hypnosis, Cognitive-Behavioral Therapy, Quality of Life, Distress, Cytokines

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Mild pr severe Haemophilia A or B
  • Age of 18 or older
  • Ability to write and read

Exclusion Criteria:

  • Other comorbid life threatening diseases, such as cancer
  • Neurological or psychiatric deficits
  • Acquired Haemophilia

Sites / Locations

  • Life and Health Sciences Research Institute

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

No Intervention

Arm Label

Hypnosis

Cognitive-Behavioral Therapy

Control Group

Arm Description

Hypnosis for the prevention and management of pain, emotional regulation and promotion of quality of life in people with Haemophilia

Cognitive Behavioral Therapy for the prevention and management of pain, emotional regulation and promotion of quality of life in people with Haemophilia

No psychological intervention - standard Haemophilia care

Outcomes

Primary Outcome Measures

Pain intensity at 1 week as assessed by Numeric Rating Scale (NRS)
Pain intensity at 3 months as assessed by NRS
Pain intensity at 6 months as assessed by NRS
Pain intensity at 12 months as assessed by NRS

Secondary Outcome Measures

Health Related Quality of Life (HRQOL) at 1 week as assessed by A36Hemofilia-Qol
HRQOL at 3 months as assessed by A36Hemofilia-Qol
HRQOL at 6 months as assessed by A36Hemofilia-Qol
HRQOL at 12 months as assessed by A36Hemofilia-Qol
Haemophilia related functional limitations at 1 week as assessed by Haemophilia Activities List (HAL)
Haemophilia related functional limitations at 3 months as assessed by HAL
Haemophilia related functional limitations at 6 months as assessed by HAL
Haemophilia related functional limitations at 12 months as assessed by HAL
Anxiety at 1 week as assessed by Patient-Reported Outcomes Measurement Information System (PROMIS)-Anxiety Short Form v1.0
Anxiety at 3 months as assessed by PROMIS-Anxiety Short Form v1.0
Anxiety at 6 months as assessed by PROMIS-Anxiety Short Form v1.0
Anxiety at 12 months as assessed by PROMIS-Anxiety Short Form v1.0
Depression at 1 week as assessed by PROMIS-Depression Short Form v1.0
Depression at 3 months as assessed by PROMIS-Depression Short Form v1.0
Depression at 6 months as assessed by PROMIS-Depression Short Form v1.0
Depression at 12 months as assessed by PROMIS-Depression Short Form v1.0
Pain Catastrophizing at 1 week as assessed by Coping Strategies Questionnaire (CSQ) Catastrophizing Subscale
Pain Catastrophizing at 3 months as assessed by CSQ Catastrophizing Subscale
Pain Catastrophizing at 6 months as assessed by CSQ Catastrophizing Subscale
Pain Catastrophizing at 12 months as assessed by CSQ Catastrophizing Subscale
Illness Perception (Personal Control) at 1 week as assessed by Revised Illness Perception Questionnaire (IPQ-R)
Illness Perception (Emotional Representation) at 1 week as assessed by IPQ-R
Illness Perception (Personal Control) at 3 months as assessed by IPQ-R
Illness Perception (Emotional Representation) at 3 months as assessed by IPQ-R
Illness Perception (Personal Control) at 6 months as assessed by IPQ-R
Illness Perception (Emotional Representation) at 6 months as assessed by IPQ-R
Illness Perception (Personal Control) at 12 months as assessed by IPQ-R
Illness Perception (Emotional Representation) at 12 months as assessed by IPQ-R
Number of joint bleeds in the previous month, at 1 week
Number of joint bleeds in the previous month, at 3 months
Number of joint bleeds in the previous month, at 6 months
Number of joint bleeds in the previous month, at 12 months
Analgesic intake in the previous month, at 1 week
Analgesic intake in the previous month, at 3 months
Analgesic intake in the previous month, at 6 months
Analgesic intake in the previous month, at 12 months
Replacement factor (VIII/IX) consumption in the previous month, at 1week
Replacement factor (VIII/IX) consumption in the previous month, at 3 months
Replacement factor (VIII/IX) consumption in the previous month, at 6 months
Replacement factor (VIII/IX) consumption in the previous month, at 12 months
Pettersson Score at 3 months
Radiologic classification of PWH joint status
Pettersson Score at 12 months
Radiologic classification of PWH joint status
Gilbert Score at 3 months
Joint health evaluation, in the domain of body structure and function (i.e. impairment), of the joints most commonly affected by bleeding in hemophilia - knees, ankles, elbows
Gilbert Score at 12 months
Joint health evaluation, in the domain of body structure and function (i.e. impairment), of the joints most commonly affected by bleeding in hemophilia - knees, ankles, elbows
IL-6 Cytokine at 3 months
IL-6 Cytokine at 12 months
IL-1β Cytokine at 6 months
IL-1β Cytokine at 12 months
IL-10 Cytokine at 6 months
IL-10 Cytokine at 12 months
TNF-α Cytokine at 6 months
TNF-α Cytokine at 12 months
C Reactive Protein at 6 months
C Reactive Protein at 12 months

Full Information

First Posted
August 9, 2016
Last Updated
March 25, 2019
Sponsor
University of Minho
Collaborators
Hospital Sao Joao
search

1. Study Identification

Unique Protocol Identification Number
NCT02870452
Brief Title
Effectiveness of Psychological Interventions in Haemophilia
Acronym
PSY_HaEMOPEQ
Official Title
Effectiveness of Two Psychological Interventions for Prevention and Management of Pain, Emotional Regulation and Promotion of Quality of Life in People With Haemophilia: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2019
Overall Recruitment Status
Completed
Study Start Date
January 9, 2018 (Actual)
Primary Completion Date
December 31, 2018 (Actual)
Study Completion Date
December 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Minho
Collaborators
Hospital Sao Joao

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the relative effectiveness of two psychological interventions, cognitive-behavioral therapy (CBT) and hypnosis (Hyp), in preventing and managing pain, regulating emotional state and improving quality of life in Portuguese PWH.
Detailed Description
22 (People with Haemophilia) PWH will be included in each group (Hypnosis, CBT and control-no intervention) (total=66). Sample size was calculated using G*Power 3.1.4 and considering the following assumptions: to perform a one-way ANOVA with fixed effects, a large effect size (f =0.4), a significance level (α - type I error) of 0.05 and a statistical power (1-β - type II error) of 0.80. The patients will be approached by clinicians of the Immunohaemotherapy Department and the psychologists for the explanation of the study, confidentiality and voluntary nature of participation. Patients who agree to participate will be asked to read and sign the Informed Consent document. Afterwards, the first assessment moment will take place in order to get a baseline assessment of each patient (T0: pre-test). Subsequently, the blind randomization to one of the 3 conditions will occur and the 4 individual intervention sessions will be scheduled, occurring in a weekly basis (90 minutes per session). The post-test assessment (T1) takes place one week after the last intervention session (in the 5th week), and the follow-up assessments (T2, T3 and T4) will occur subsequently at 3 months, 6 months and one year post-intervention. A physiological assessment will be performed at T1, T2 and T4. This will be performed through the collection of blood samples in order to achieve a systemic evaluation of pro-inflammatory and anti-inflammatory cytokines. A CBC (Complete Blood Count) with White Blood Count and C Reactive Protein (CRP) analysis will also be performed. Upon arrival at the Immunohaemotherapy Department (between 9:30 am and 1:30 pm), patients will undergo sample blood collection and EDTA-samples will be transported immediately to the lab. In the lab, blood samples are centrifuged 15 minutes at 3.000 rpm, and plasma aliquoted and stored in a freezer at -80 ºC, until further analysis. Plasma levels of cytokines (IL-6, IL-1β, TNF-α, IL-10) are assayed in duplicate using ultra-sensitive multiplex human ELISA kits (Life Technologies®). Functional Assessment of the joints will be performed through the Gilbert (based on clinical evaluation) and Pettersson Scores (based on X-ray and ultrasonography). All study procedures will comply with the applicable ethical guidelines.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Haemophilia
Keywords
Haemophilia, RCT, Pain, Hemarthrosis, Hypnosis, Cognitive-Behavioral Therapy, Quality of Life, Distress, Cytokines

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Hypnosis
Arm Type
Experimental
Arm Description
Hypnosis for the prevention and management of pain, emotional regulation and promotion of quality of life in people with Haemophilia
Arm Title
Cognitive-Behavioral Therapy
Arm Type
Experimental
Arm Description
Cognitive Behavioral Therapy for the prevention and management of pain, emotional regulation and promotion of quality of life in people with Haemophilia
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
No psychological intervention - standard Haemophilia care
Intervention Type
Behavioral
Intervention Name(s)
Hypnosis
Intervention Description
4 weekly individual sessions of Hypnosis, conducted by a certified psychologist, with the approximate duration of 90 minutes.
Intervention Type
Behavioral
Intervention Name(s)
Cognitive-Behavioral Therapy
Intervention Description
4 weekly individual sessions of CBT, conducted by a certified psychologist, with the approximate duration of 90 minutes.
Primary Outcome Measure Information:
Title
Pain intensity at 1 week as assessed by Numeric Rating Scale (NRS)
Time Frame
1 week post-intervention
Title
Pain intensity at 3 months as assessed by NRS
Time Frame
3 months post-intervention
Title
Pain intensity at 6 months as assessed by NRS
Time Frame
6 months post-intervention
Title
Pain intensity at 12 months as assessed by NRS
Time Frame
12 months post-intervention
Secondary Outcome Measure Information:
Title
Health Related Quality of Life (HRQOL) at 1 week as assessed by A36Hemofilia-Qol
Time Frame
1 week
Title
HRQOL at 3 months as assessed by A36Hemofilia-Qol
Time Frame
3 months
Title
HRQOL at 6 months as assessed by A36Hemofilia-Qol
Time Frame
6 months
Title
HRQOL at 12 months as assessed by A36Hemofilia-Qol
Time Frame
12 months
Title
Haemophilia related functional limitations at 1 week as assessed by Haemophilia Activities List (HAL)
Time Frame
1 week
Title
Haemophilia related functional limitations at 3 months as assessed by HAL
Time Frame
3 months
Title
Haemophilia related functional limitations at 6 months as assessed by HAL
Time Frame
6 months
Title
Haemophilia related functional limitations at 12 months as assessed by HAL
Time Frame
12 months
Title
Anxiety at 1 week as assessed by Patient-Reported Outcomes Measurement Information System (PROMIS)-Anxiety Short Form v1.0
Time Frame
1 week
Title
Anxiety at 3 months as assessed by PROMIS-Anxiety Short Form v1.0
Time Frame
3 months
Title
Anxiety at 6 months as assessed by PROMIS-Anxiety Short Form v1.0
Time Frame
6 months
Title
Anxiety at 12 months as assessed by PROMIS-Anxiety Short Form v1.0
Time Frame
12 months
Title
Depression at 1 week as assessed by PROMIS-Depression Short Form v1.0
Time Frame
1 week
Title
Depression at 3 months as assessed by PROMIS-Depression Short Form v1.0
Time Frame
3 months
Title
Depression at 6 months as assessed by PROMIS-Depression Short Form v1.0
Time Frame
6 months
Title
Depression at 12 months as assessed by PROMIS-Depression Short Form v1.0
Time Frame
12 months
Title
Pain Catastrophizing at 1 week as assessed by Coping Strategies Questionnaire (CSQ) Catastrophizing Subscale
Time Frame
1 week
Title
Pain Catastrophizing at 3 months as assessed by CSQ Catastrophizing Subscale
Time Frame
3 months
Title
Pain Catastrophizing at 6 months as assessed by CSQ Catastrophizing Subscale
Time Frame
6 months
Title
Pain Catastrophizing at 12 months as assessed by CSQ Catastrophizing Subscale
Time Frame
12 months
Title
Illness Perception (Personal Control) at 1 week as assessed by Revised Illness Perception Questionnaire (IPQ-R)
Time Frame
1 week
Title
Illness Perception (Emotional Representation) at 1 week as assessed by IPQ-R
Time Frame
1 week
Title
Illness Perception (Personal Control) at 3 months as assessed by IPQ-R
Time Frame
3 months
Title
Illness Perception (Emotional Representation) at 3 months as assessed by IPQ-R
Time Frame
3 months
Title
Illness Perception (Personal Control) at 6 months as assessed by IPQ-R
Time Frame
6 months
Title
Illness Perception (Emotional Representation) at 6 months as assessed by IPQ-R
Time Frame
6 months
Title
Illness Perception (Personal Control) at 12 months as assessed by IPQ-R
Time Frame
12 months
Title
Illness Perception (Emotional Representation) at 12 months as assessed by IPQ-R
Time Frame
12 months
Title
Number of joint bleeds in the previous month, at 1 week
Time Frame
1 week
Title
Number of joint bleeds in the previous month, at 3 months
Time Frame
3 months
Title
Number of joint bleeds in the previous month, at 6 months
Time Frame
6 months
Title
Number of joint bleeds in the previous month, at 12 months
Time Frame
12 months
Title
Analgesic intake in the previous month, at 1 week
Time Frame
1 week
Title
Analgesic intake in the previous month, at 3 months
Time Frame
3 months
Title
Analgesic intake in the previous month, at 6 months
Time Frame
6 months
Title
Analgesic intake in the previous month, at 12 months
Time Frame
12 months
Title
Replacement factor (VIII/IX) consumption in the previous month, at 1week
Time Frame
1 week
Title
Replacement factor (VIII/IX) consumption in the previous month, at 3 months
Time Frame
3 months
Title
Replacement factor (VIII/IX) consumption in the previous month, at 6 months
Time Frame
6 months
Title
Replacement factor (VIII/IX) consumption in the previous month, at 12 months
Time Frame
12 months
Title
Pettersson Score at 3 months
Description
Radiologic classification of PWH joint status
Time Frame
3 months
Title
Pettersson Score at 12 months
Description
Radiologic classification of PWH joint status
Time Frame
12 months
Title
Gilbert Score at 3 months
Description
Joint health evaluation, in the domain of body structure and function (i.e. impairment), of the joints most commonly affected by bleeding in hemophilia - knees, ankles, elbows
Time Frame
3 months
Title
Gilbert Score at 12 months
Description
Joint health evaluation, in the domain of body structure and function (i.e. impairment), of the joints most commonly affected by bleeding in hemophilia - knees, ankles, elbows
Time Frame
12 months
Title
IL-6 Cytokine at 3 months
Time Frame
3 months
Title
IL-6 Cytokine at 12 months
Time Frame
12 months
Title
IL-1β Cytokine at 6 months
Time Frame
6 months
Title
IL-1β Cytokine at 12 months
Time Frame
12 months
Title
IL-10 Cytokine at 6 months
Time Frame
6 months
Title
IL-10 Cytokine at 12 months
Time Frame
12 months
Title
TNF-α Cytokine at 6 months
Time Frame
6 months
Title
TNF-α Cytokine at 12 months
Time Frame
12 months
Title
C Reactive Protein at 6 months
Time Frame
6 months
Title
C Reactive Protein at 12 months
Time Frame
12 months

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Mild pr severe Haemophilia A or B Age of 18 or older Ability to write and read Exclusion Criteria: Other comorbid life threatening diseases, such as cancer Neurological or psychiatric deficits Acquired Haemophilia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Patrícia R Pinto, PhD
Organizational Affiliation
Life and Health Sciences Research Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Life and Health Sciences Research Institute
City
Braga
ZIP/Postal Code
4710-057
Country
Portugal

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
28871021
Citation
Pinto PR, Paredes AC, Costa P, Carvalho M, Lopes M, Fernandes S, Pedras S, Almeida A. Effectiveness of two psychological interventions for pain management, emotional regulation and promotion of quality of life among adult Portuguese men with haemophilia (PSY-HaEMOPEQ): study protocol for a single-centre prospective randomised controlled trial. BMJ Open. 2017 Sep 3;7(9):e016973. doi: 10.1136/bmjopen-2017-016973.
Results Reference
derived

Learn more about this trial

Effectiveness of Psychological Interventions in Haemophilia

We'll reach out to this number within 24 hrs